• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Mind Medicine Mindmed Inc (NQ: MNMD )

    6.140 -0.160 (-2.54%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Mind Medicine Mindmed Inc

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    27 28 Next >
    Psychedelic Drug Stocks +6% Last Week Vs. -13% Previous Week
    The psychedelic compound-based drug market is expected to triple over the next few years, creating many winning stocks in the years to come. 
    Via Talk Markets
    Psychedelic Compound-Based Drug Stocks Portfolio -13% W/e Sept. 6th
    While the psychedelic compound-based drug market is expected to triple over the next few years which should create many winning stocks in the years to come, the stocks of the companies involved are... 
    Via Talk Markets
    Our Psychedelic Compound-Based Clinical-Stage Drug Stocks Portfolio Was Down 16% In August
    The psychedelic compound-based drug market is expected to triple over the next few years which should create many winning stocks in the years to come and, to monitor their progress we present a... 
    Via Talk Markets
    Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
    The global psychedelic drugs market is projected to grow by USD 1.37 billion by 2028, driven by mental health needs and AI advancements in drug development. 
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Largest Psychedelic Compound -Based Clinical-Stage Drug Stocks Up 6% Last Week
    Opportunities to invest in psychedelic stocks are emerging for those willing to get in early, and the 4 largest psychedelic compound-based portfolio drug discovery companies are up 5.9% in the past... 
    Via Talk Markets
    Psychedelics Company MindMed Prices Public Offering Aiming To Raise $75M
    Via Benzinga
    Psychedelic Compound-Based Drug Stocks Portfolio: Up 17.5% In July; Down 19% MTD
    This article highlights the 4 largest market cap clinical-stage psychedelic compound-based drug discovery companies with their stock performances MTD, in July, their areas of focus, and their latest... 
    Via Talk Markets
    MNMD Stock Earnings: Mind Medicine Misses EPS for Q2 2024
    MNMD stock results show that Mind Medicine missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
    Jamaica introduces its first legal psilocybin products in pharmacies through a historic partnership between PATOO and Fontana Pharmacy. 
    Via Benzinga
    Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD
    The 10 clinical-stage AI-focused and psychedelic compound-based drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio are UP 12.8% MTD after having gone DOWN 13.2%, on average,... 
    Via Talk Markets
    3 Psychedelic Stocks to Ride to the Moon and Beyond
    Psychedelic stocks are a hot, trending area of investment as the FDA continues to weigh regulatory considerations that will open the market. 
    Via InvestorPlace
    Exposures Product Safety
    FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals
    Biotech stocks are on the verge of a comeback after a period of underperformance amid a wave of FDA approvals. 
    Via InvestorPlace
    Exposures Product Safety
    Clinical-Stage BioTech Drug Stocks Declined 13% In June
    Our BioTech Drug Stocks Portfolio was DOWN 13.2% in June. Before proceeding read 
    Via Talk Markets
    Groundbreaking Fentanyl Vaccine Being Developed To Prevent Fatal Overdoses, Startup Secures $10M
    The initiative focuses on commercializing academic research aimed at preventing deadly fentanyl from reaching the brain. 
    Via Benzinga
    Largest Clinical-Stage BioTech Drug Stocks Declined 6%
    Of the 10 clinical-stage AI-focused and psychedelic compound-based small cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, only 1 advanced this week. On average they... 
    Via Talk Markets
    Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024
    Discover top strong buy penny stocks, poised for impressive gains as market indices climb, offering unique opportunities. 
    Via InvestorPlace
    Largest Psychedelic Compound Based Drug Stocks Fell 13% Last Week - Here's Why
    Stocks for companies developing psychedelic treatments fell last Wednesday after advisers to the Food and Drug Administration voted against a mental-health therapy using the drug MDMA. 
    Via Talk Markets
    Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
    FDA panel rejects MDMA therapy for PTSD, citing lack of evidence for benefits outweighing risks. Psychedelic stocks take a hit, with CYBN, MNMD, and ATAI down. FDA not bound by decision. 
    Via Benzinga
    Exposures Product Safety
    What's Going On With MindMed And Psychedelic Stocks?
    Mind Medicine (MindMed) shares are trading lower Wednesday after a Food and Drug Administration (FDA) panel rejected the approval of MDMA therapy for people with post-traumatic stress disorder (PTSD).... 
    Via Benzinga
    DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Why Stitch Fix Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Largest Clinical-Stage BioTech Drug Stocks Declined Slightly Last Week
    This article highlights the performances last week and MTD of the 10 clinical-stage AI-powered and psychedelic compound-based small cap drug discovery companies along with their areas of focus in our... 
    Via Talk Markets
    The Time Traveler’s Portfolio: 3 Stocks to Buy Now for Massive Returns by 2034
    These long-term stocks to buy may seem speculative today, but so did Nvidia in 2024 -- and they may match the chipmaker's returns by 2034. 
    Via InvestorPlace
    Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
    President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). 
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Jim Cramer: This Industrial Company Is 'Absolutely Terrific', Recommends Buying Modine Manufacturing
    Regarding Hertz, Jim Cramer said, "I don't want you to sell, and I don't want you to double down. Let's just see if it can't go higher." 
    Via Benzinga
    Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week
    Via Talk Markets
    Seritage Growth Properties Posts Q1 Loss, Joins Fortrea Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Via Benzinga
    Top Russell 2000 Picks: 3 Small-Cap Stocks to Scoop Up This May
    Some of the top Russell 2000 stocks to buy are those that few investors pay attention to but offer great potential nonetheless. 
    Via InvestorPlace
    Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine
    These biotech breakthrough stocks give investors a glimpse into medicine's future -- and massive moneymaking opportunities to boot. 
    Via InvestorPlace
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    27 28 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.